Objective: To explore the application effect of early rehabilitation nursing led by stroke specialist nurses in patients with ischemic stroke. Method: 120 patients with ischemic stroke admitted to the People's Hospital of Xinjiang Uygur Autonomous Region from January 2018 to January 2019 were selected as the study subjects. According to the random number table method, the patients were divided into a control group of 60 cases and an observation group of 60 cases. The control group received routine nursing care for ischemic stroke; The observation group implemented an early rehabilitation nursing model led by stroke specialist nurses. Compare the degree of neurological impairment, daily living activity, hemiplegic limb motor function, and satisfaction between two groups of patients. After the intervention, the observation group's National Institutes of Health Stroke Scale (NIHSS), Barthel Index Rating Scale (BI), and Simplified Fugl Meyer Motor Function (FMA) scores were (12.37 ± 2.65), (43.81 ± 5.63), and (52.36 ± 9.01), respectively, which were better than the control group's (14.21 ± 2.43), (40.28 ± 4.54), and (45.25 ± 8.03) scores (t=5.126, -0.239, -2.45, all P<0.05); The total satisfaction score of the observation group patients was (90.05 ± 1.61) points, which was higher than the control group's (80.19 ± 1.62) points (t=-5.267, P<0.05). Conclusion: The implementation of an early rehabilitation nursing model led by stroke specialist nurses can effectively improve patients' limb dysfunction, enhance their self-management ability, standardize the early rehabilitation nursing workflow, and improve work quality.
期刊介绍:
Since its inception, the journal "Chinese Primary Medicine" has adhered to the development strategy of "based in China, serving the grassroots, and facing the world" as its publishing concept, reporting a large amount of the latest medical information at home and abroad, prospering the academic field of primary medicine, and is praised by readers as a medical encyclopedia that updates knowledge. It is a core journal in China's medical and health field, and its influence index (CI) ranks Q2 in China's academic journals in 2022. It was included in the American Chemical Abstracts in 2008, the World Health Organization Western Pacific Regional Medical Index (WPRIM) in 2009, and the Japan Science and Technology Agency Database (JST) and Scopus Database in 2018, and was included in the Wanfang Data-China Digital Journal Group and the China Academic Journal Comprehensive Evaluation Database.